Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells ...

Osteoarthritis (OA) imposes huge social and economic burdens on our society, causing pain and disability as well as reduced quality of life in individuals with the condition Owing to sophisticated ...

Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models. Administering ... This work is one of the latest examples of therapeutic nanosponges developed ...

The intravenous administration of monocytic myeloid-derived suppressor cells, or M-MDSCs, proved promising in treating rheumatoid arthritis in mice, inhibiting T cell proliferation, as well as B ...

WASHINGTON (HealthDay News) -- Researchers believe they've developed an important new tool in understanding rheumatoid arthritis: a genetically altered mouse that closely mimics the disease in humans.

In vivo experiments using the collagen-induced arthritis mouse model showed that EFC alleviated inflammation, slowed disease progression, and preserved joint and bone integrity. RNA sequencing ...

Using a mouse model of rheumatoid arthritis, scientists have discovered that a form of cellular immunotherapy by intravenous administration of monocytic myeloid-derived suppressor cells ...

One group was treated with control solution and the other group was treated with M-MDSCs isolated from mouse donors with arthritis. All mice received five treatments through intravenous injections.